Back to Resource Center

MPT Dosage-Form Specific Target Product Profiles (TPPs)

In 2012, Initiative for Multipurpose Prevention Technologies (IMPT) managed an exercise to define general target attributes for MPT products. While prioritizing specific MPT product dosage forms (i.e., long acting injectables, intravaginal rings, and on-demand products), it became clear that it was necessary to move beyond a listing of general MPT product attributes and to develop more specific TPPs focused on each type of prioritized product dosage form. These dosage-form specific TPPs focused on defining the necessary attributes and required supporting data for the successful development of impactful MPT products.

Learn more about TPPs and the development of the MPT Dosage-Form Specific TPPs by reading our TPP Technical Brief.

 

 

January 2014

Click for full info +

MPT Dosage-Form Specific Target Product Profiles (TPPs)

MPT Dosage-Form Specific Target Product Profiles (TPPs)
2014

In 2012, Initiative for Multipurpose Prevention Technologies (IMPT) managed an exercise to define general target attributes for MPT products. While prioritizing specific MPT product dosage forms (i.e., long acting injectables, intravaginal rings, and on-demand products), it became clear that it was necessary to move beyond a listing of general MPT product attributes and to develop more specific TPPs focused on each type of prioritized product dosage form. These dosage-form specific TPPs focused on defining the necessary attributes and required supporting data for the successful development of impactful MPT products.

Learn more about TPPs and the development of the MPT Dosage-Form Specific TPPs by reading our TPP Technical Brief.

 

 

CAMI Health

In this Technical Brief:
Health Risk(s):

  • HIV
  • STI / STD
  • Unintended Pregnancy
  • Product Type(s):

  • ARVs
  • IVR (Intravaginal Rings)
  • Topic(s):

  • Drug Interactions
  • MPTs
  • Product Development
  • Product Introduction / Uptake
  • Product Trials
  • Region(s):

  • Global

  • Full Info:


    Resource Type:

    Technical Brief

    Citation:

    These dosage-form specific TPPs focused on defining the necessary attributes and required supporting data for the successful development of impactful MPT products.

    Authors:

    CAMI Health

    Health Risks(s):

    • HIV
    • STI / STD
    • Unintended Pregnancy

    Product type(s):

    • AVRs
    • IVR

    Topic(s):

    • DrugInteractions
    • MPTs
    • Development
    • Product Introduction
    • Trials

      Region(s)

      • Global

      Back to Resource Center